A carregar...
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
INTRODUCTION: Switching therapy studies are usually designed as second-line antiretroviral treatment (ART) in patients without previous virologic failures. Combined ART (cART) with DRV/r and ETR has a good pharmacokinetic profile, high genetic barrier and has been proved as rescue therapy. The aim o...
Na minha lista:
| Publicado no: | J Int AIDS Soc |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International AIDS Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225347/ https://ncbi.nlm.nih.gov/pubmed/25397547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19803 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|